An observational study in Hip Fractures, Mobility Limitation and Independence, sponsored by Hospices Civils de Lyon. Recruiting at 1 site in France. Open to participants aged 75 Years and older. Per ClinicalTrials.gov, last updated 2026-09-03.
Sponsored by Hospices Civils de Lyon · Observational
The incidence of hip fractures in France is 50,000 cases per year among women and 16,000 among men, with a 1-year mortality rate of 20-24%. After a fracture, 10-30% of patients become functionally dependent. The increasing aging of the population and the rise in dependency are likely to worsen the situation of older patients in hospital settings.
Several tools are available to assess functional independence, including the New Mobility Score (NMS), which evaluates mobility through three domains: mobility indoors, mobility outdoors, and shopping activities. The NMS has shown good performance in predicting patient mortality and functional recovery, and its use is recommended in clinical practice. However, the French version of the NMS has not yet been validated.
The French validation of the NMS is important to facilitate its implementation in clinical practice and research, particularly because of its simplicity and the need for rapid assessment tools for healthcare professionals. A French version of the NMS has been translated, and the MOB-SCORE study aims to assess its reliability and validity among healthcare professionals caring for patients with hip fractures.
842 studies on the registry are indexed under Hip Fractures; 165 are open to participants now.
This study's planned enrollment of 100 is below the median of 149 across 280 observational studies indexed under Hip Fractures.
Browse Hip Fractures studies →Hospices Civils de Lyon is the lead sponsor of 1,866 studies on the registry; 448 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Subjects admitted to a hospital ward following a hip fracture
Inclusion Criteria:
Exclusion Criteria: no exclusion criteria
Subjects aged 75 years and over, admitted to a hospital service following a hip fracture (per trochanteric or femoral neck) and having received surgical treatment (osteosynthesis or arthroplasty).
Other: Questionnaires
New Mobility Score (NMS), Measure of Functional Independence (MIF), Cumulated Ambulation Score (CAS), Mini-Mental State Examination (MMSE).
Inter-rater reliability of the New Mobility Score (NMS)
The New Mobility Score (NMS) assesses mobility in three domains (indoors, outdoors, and while shopping). For each domain, a score ranging from 0 (unable to perform the task) to 3 (able to perform the task independently) is assigned, with a total score ranging from 0 to 9. A score of ≤6 indicates functional impairment, whereas a score of \>6 indicates a high pre-fracture level of mobility in patients with hip fracture. The NMS will be rated by a physiotherapist and an adapted physical activity (APA) instructor.
Time frame: Within 7 days following the fracture surgery
Internal consistency of the New Mobility Score (NMS)
Internal consistency of the New Mobility Score (NMS) items.
Time frame: Within 7 days following the fracture surgery
Convergent validity of the New Mobility Score (NMS) with other functional independence scales, cognitive status and age.
Correlation between the New Mobility Score (NMS) and: * Measure of Functional Independence (MIF): 18 items assessing 6 functional domains. Each item is scored from 1 (total assistance) to 7 (complete independence). The total score ranges from 18 to 126. * Cumulated Ambulation Score (CAS): independence in 3 activities (getting in and out of bed, sitting down and rising from a chair, walking ability). Each activity is scored on a scale from 0 (unable despite human assistance) to 2 (able without human assistance), with a total score ranging from 0 to 6 (6 indicating independent ambulation). * Mini-Mental State Examination (MMSE): 30 questions divided into 6 categories. For each question, a correct answer scores 1 point (0 otherwise), with a total score ranging from 0 to 30. * Age
Time frame: Within 7 days following the fracture surgery
Predictive validity of mortality at postoperative day 30.
Correlation between the New Mobility Score (NMS) and vital status at postoperative day 30.
Time frame: Within 30 days following the fracture surgery
Discriminatory validity based on place of residence.
Comparison of the New Mobility Score (NMS) according to pre-fracture living arrangements: living alone versus living in a nursing home/with family.
Time frame: Within 7 days following the fracture surgery
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.